Table 2.
Control subjects | T2DM patients | DN patients | |
---|---|---|---|
Plasma | |||
IL-6 (pg/ml) | 3.685 ± 0.471 | 4.159 ± 0.443 | 7.397 ± 2.196*# |
TNF-α (pg/ml) | 2.010 ± 0.284 | 2.373 ± 0.132 | 8.087 ± 3.122*# |
TTP (pg/ml) | 284.19 ± 20.61 | 196.14 ± 17.11* | 81.34 ± 16.51*# |
Urine | |||
IL-6 (pg/ml) | 2.373 ± 0.585 | 4.242 ± 0.668 | 6.176 ± 0.664*# |
TNF-α (pg/ml) | 7.202 ± 1.42 | 11.241 ± 1.53 | 22.639 ± 1.47*# |
TTP (pg/ml) | 244.19 ± 18.37 | 160.03 ± 19.41* | 68.61 ± 17.49*# |
*Compared to control subjects, P < 0.05.
#Compared to T2DM patients, P < 0.05.